Skip to main content
TipRanks
Go Ultimate75% OFF

Opus Genetics (IRD) Income Statement

1,367 Followers

Opus Genetics Income Statement

Last quarter (Q3 2026), Opus Genetics's total revenue was $1.14M, a decrease of 63.07% from the same quarter last year. In Q3, Opus Genetics's net income was $-46.49M. See Opus Genetics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 14.20M$ 10.99M$ 19.05M$ 39.85M$ 589.00K
$ 14.20M$ 10.99M$ 19.05M$ 39.85M$ 589.00K
$ 52.80M$ 73.07M$ 29.61M$ 21.62M$ 23.29M
Depreciation and Amortization$ 53.00K$ 10.00K$ 6.00K$ 4.00K$ 4.00K
$ -48.07M$ -57.52M$ -9.97M$ 18.22M$ -56.69M
$ -38.60M$ -62.07M$ -10.56M$ 18.23M$ -22.70M
$ -10.99M$ 4.54M$ 589.00K$ -23.00K$ -33.99M
$ -49.59M$ -57.53M$ -9.97M$ 18.20M$ -56.69M
$ -49.59M$ -57.53M$ -9.99M$ 17.89M$ -56.69M
Per Share Metrics
Basic EPS$ -0.80$ -2.15$ -0.46$ 0.90$ -3.82
Diluted EPS$ -0.80$ -2.15$ -0.46$ 0.87$ -3.82
Weighted Average Shares Outstanding62.22M26.72M21.59M19.93M14.85M
Weighted Average Shares Outstanding (Diluted)62.22M26.72M21.59M20.60M14.85M

Currency in USD

Opus Genetics Earnings and Revenue History

-100M-50M050M-12000 %-6000 %0 %6000 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin